Anticancer activity of the Aurora a kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies

Danielle C. Chinn, William S. Holland, Philip Mack

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Anticancer activity of the Aurora a kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies'. Together they form a unique fingerprint.

Medicine & Life Sciences